PES14 RESPONSIVENESS OF SELF-REPORTED VISUAL FUNCTIONING IN AGE-RELATED MACULAR DEGENERATION (AMD) PATIENTS TO GENERAL HEALTH AND CHANGES IN VISUAL ACUITY IN A PHASE I/II RANDOMIZED CONTROLLED TRIAL OF LUCENTISTM (RANIBIZUMAB; RHUFAB V2)
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65992-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65992-X/fulltext
Title :
PES14 RESPONSIVENESS OF SELF-REPORTED VISUAL FUNCTIONING IN AGE-RELATED MACULAR DEGENERATION (AMD) PATIENTS TO GENERAL HEALTH AND CHANGES IN VISUAL ACUITY IN A PHASE I/II RANDOMIZED CONTROLLED TRIAL OF LUCENTISTM (RANIBIZUMAB; RHUFAB V2)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65992-X&doi=10.1016/S1098-3015(10)65992-X
First page :
Section Title :
Open access? :
No
Section Order :
361